Nanomedicine News

RSS

Inexpensive Drug Sensor with Gold Nano Domes Identifies Fluid Contents in IV Lines

Today, computerized smart systems can deliver drugs intravenously in exact volumes to hospital patients. However, these systems cannot recognize which medications are in the tubing nor can they determine the concentration of the drug in the tubing. This lack of precise information can lead to medication errors with serious consequences.

20 Sep 2013

New Nanoparticle Treatment for Gonorrhea Based on Anti-Cancer Drug

A new gonorrhea treatment, based on an anti-cancer therapy developed by a Buffalo startup company, has successfully eliminated gonococcal infection in female mice and prevented reinfection, according to research published yesterday by UB scientists in the Journal of Infectious Diseases.

20 Sep 2013

Research Opens New Window into Nanoscale Neuronal Activity

A new technique that allows scientists to measure the electrical activity in the communication junctions of the nervous systems has been developed by a researcher at Queen Mary University of London.

19 Sep 2013

Microscopic, Bottle-Like Structures can Release Drugs Inside the Body

Microscopic, bottle-like structures with corks that melt at precisely-controlled temperatures could potentially release drugs inside the body or fragrances onto the skin, according to a recently published study.

From Georgia Institute of Technology 19 Sep 2013

US Patent Office Awards Patent to Newcyte for Carbon Nanostructure Artificial Retinal Implant

The U.S. Patent Office has awarded patent no. 8,433,417 to Newcyte Inc. for a carbon nanostructure artificial retinal implant. Newcyte was purchased in 2009 by Natcore Technology Inc.

18 Sep 2013

NanoViricides Improves Broad-Spectrum Anti-HIV Nanoviricide

NanoViricides, Inc. reports that it has successfully improved upon its previous lead anti-HIV drug candidate, based on cell culture studies. An improved broad-spectrum anti-HIV nanoviricide that inhibited two distinctly different types of HIV-1 viruses equally well has been identified.

17 Sep 2013

Sorrento to Present Data on Cynviloq Nanoparticle Paclitaxel for Ovarian Cancer at AACR Conference

Sorrento Therapeutics, Inc. announced today it will present the clinical data for Cynviloq™ (IG-001), which resulted in its approval as 1st line treatment of ovarian cancer by Korean FDA in March of 2013.

17 Sep 2013

NanoBio to Present New Safety Data of Nanoemulsion Adjuvanted Intramuscular Vaccine for RSV Prevention

NanoBio Corporation today announced that the company will present new data at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting showing the safety and efficacy of a nanoemulsion (NE) adjuvanted intramuscular vaccine for the prevention of respiratory syncytial virus (RSV).

From BlueWillow Biologics 12 Sep 2013

Nanoparticle-Delivered miR-200 Reduces Cancer Burden and Inhibits Metastasis

A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor’s ability to weave new blood vessels to support itself, researchers at The University of Texas MD Anderson Cancer Center report today in Nature Communications.

12 Sep 2013

Novavax Reports Positive Findings from RSV F Nanoparticle Vaccine Studies at 53rd ICAAC

Novavax, Inc. a clinical-stage biopharmaceutical company creating novel recombinant nanoparticle vaccines and vaccine adjuvants, today reported positive findings from recent clinical and preclinical studies of its respiratory syncytial virus F-protein (RSV F) nanoparticle vaccine candidate in poster sessions at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Denver, Colorado.

From Novavax Inc. 12 Sep 2013